Pharma channel feed

Mer­ck touts topline PhI­II Keytru­da da­ta in pre-surgery breast can­cer treat­ment

Last year
R&D

US gov­ern­ment to ac­quire $138M worth of Tpoxx dos­es

Last year
Manufacturing

Want­ed: More phar­ma field med­ical teams, as study finds they can amp drug launch sales

Last year
Marketing

Sanofi, BioN­Tech cut ear­ly-stage mR­NA can­cer ther­a­py from pipeline

Last year
R&D

Alk­er­mes hikes up 2023 fi­nan­cials by $425M af­ter In­ve­ga li­cense fight win against John­son & John­son

Last year

Mer­ck touts pos­i­tive PhI­II re­sults for 21-va­lent pneu­mo­coc­cal vac­cine can­di­date

Last year

Take­da re­veals PhII fail for rare ge­net­ic con­di­tion, looks to new prod­uct pipeline to bol­ster growth

Last year
R&D

BMS looks to new prod­uct port­fo­lio as rev­enues slide due to Revlim­id loss­es

Last year

NASH or MASH? Name changes to es­tab­lished con­di­tion stir up con­fu­sion in liv­er dis­ease com­mu­ni­ty

Last year
Marketing

As pres­sure mounts to take ac­tion on drug short­ages, law­mak­ers seek to boost pro­duc­tion in the US

Last year
FDA+
Manufacturing

As Ab­b­Vie cel­e­brates bet­ter-than-ex­pect­ed earn­ings, CEO Rick Gon­za­lez force­ful­ly de­fends pipeline

Last year

Pfiz­er brings on­col­o­gy R&D leader in­to C-suite, parts ways with de­vel­op­ment chief William Pao af­ter just 16 months

Last year
People

Ot­su­ka, Lund­beck­'s new cam­paign spot­lights ag­i­ta­tion symp­toms in Alzheimer’s dis­ease

Last year
Marketing

GSK bull­ish on RSV vac­cine bat­tle against Pfiz­er, ships first Arexvy dose

Last year
Marketing

Mer­ck­'s $1.4B cy­ber­at­tack suit goes to New Jer­sey Supreme Court

Last year
Law

Ab­b­Vie's pso­ri­a­sis drug Skyrizi beats out Am­gen's block­buster in PhIV head-to-head study

Last year

An­oth­er dosage of Eli Lil­ly’s Moun­jaro is in short­age

Last year
Manufacturing

House, Sen­ate com­mit­tees mark up PBM bills as mo­men­tum for re­form mounts

Last year
FDA+

Phar­ma ad spend­ing jumps 12% in first half of 2023, ad track­er says

Last year
Marketing

Oc­taphar­ma wins FDA ap­proval for drug to ur­gent­ly re­verse ef­fects of blood thin­ners

Last year
FDA+

Ther­mo Fish­er's rev­enue falls in Q2 amid 'chal­leng­ing' cli­mate for biotechs and in Chi­na

Last year
Manufacturing

Finnish man­u­fac­tur­er to in­vest $55M+ in new fa­cil­i­ty for AAV ther­a­pies

Last year
Cell/Gene Tx
Manufacturing

GSK pulls plans to mar­ket ane­mia drug in EU and oth­er mar­kets, cit­ing 're­duced op­por­tu­ni­ty'

Last year

Boehringer In­gel­heim, Eli Lil­ly's Jar­diance nabs ap­proval in Eu­rope for chron­ic kid­ney dis­ease

Last year
FDA+
First page Previous page 112113114115116117118 Next page Last page
A service from the Financial Times